Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 7/2015

Open Access 01-09-2015 | Original Paper

Recommendation of rotavirus vaccination and herd effect: a budget impact analysis based on German health insurance data

Authors: Alexander Karmann, Andrea Jurack, Daniel Lukas

Published in: The European Journal of Health Economics | Issue 7/2015

Login to get access

Abstract

The objective of this study was to assess the budget impact and health effects of introducing rotavirus (RV) vaccination in Saxony, Germany, from a health insurance perspective. Special emphasis is given to the herd effect. We analyzed direct medical and non-medical costs of RV infection for Social Health Insurance between 2007 and 2010 based on 360,000 routine data observations from the AOK PLUS for children below 5 years of age. We compared the actual annual number of RV cases (vaccination scenario) with the number derived from 2005 (no vaccination, base case scenario). The vaccination coverage rate has increased from 5 % to 61 % between 2007 and 2010. The number of RV cases decreased by 21 % from 32,274 in 2007 to 25,614 in 2010. Based on vaccination coverage, the total cost savings per 1,000 children due to RV vaccination was estimated to be 39,686 Euros. The overall share of outpatient costs was 60 %. Mean gross cost savings were expected to be 304 Euros per avoided case. The net cost savings were expected to be 19 Euros per avoided case. About 59 % of total savings was due to herd protection resulting from increasing vaccine rates. The herd effect per avoided case increased with increasing vaccine coverage. Incidence of RV cases, vaccination costs and days absent from work were sensitive parameters. This retrospective analysis showed that the increase in RV vaccination coverage in Saxony has been budget neutral if not cost saving for sick funds.
Literature
1.
Koch, J., Wiese-Posselt, M.: Epidemiology of RV infections in children less than 5 years of age: Germany, 2001–2008. Pediatr. Infect. Dis. J. 30, 112–117 (2011)CrossRefPubMed
2.
Giaquinto, C., Van Damme, P., Huet, F., Gothefors, L., Van der Wielen, M.: Costs of community-acquired pediatric RV gastroenteritis in 7 European countries: the REVEAL study. J. Infect. Dis. 195(Suppl 1), S36–S44 (2007)CrossRefPubMed
3.
Beier, D., Bigl, H., Bigl, S., Borte, M.: Rotavirus impfung und Erfahrungen mit der Impfempfehlung in Sachsen 2010. Ärzteblatt Sachsen 4, 161–165 (2011)
4.
Forster, J., Guarino, A., Parez, N., Moraga, F., Roman, E., Mory, O., Tozzi, A.E., de Aguileta, A.L., Wahn, U., Graham, C., Berner, R., Ninan, T., Barberousse, C., Meyer, N., Soriano-Gabarró, M., RV Study Group: Hospital-based surveillance to estimate the burden of RV gastroenteritis among European children younger than 5 years of age. Pediatrics 123, e393–e400 (2009)CrossRefPubMed
5.
Littmann, M.: Krankheitslast durch akute RV-Gastroenteritis bei Kindern <5 Jahre. Der deutsche Beitrag zur REVEAL-Studie. Pädiatr. Praxis 70, 433–444 (2007)
6.
Parashar, U.D., Hummelman, E.G., Bresee, J.S., Miller, M.A., Glass, R.I.: Global illness and deaths caused by RV disease in children. Emerg. Infect. Dis. 9, 565–572 (2003)PubMedCentralCrossRefPubMed
7.
Soriano-Gabarro, M., Mrukowicz, J., Vesikari, T., Verstraeten, T.: Burden of RV disease in European Union countries. Pediatr. Infect. Dis. J. 25(Suppl 1), 7–11 (2006)CrossRef
8.
Dudareva-Vizule, S., Koch, J., An der Heiden, M., Oberle, D., Keller-Stanislawski, B., Wichmann, O.: Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany. Hum. Vaccin. Immunother. 8(10), 1407–1415 (2012)PubMedCentralCrossRefPubMed
9.
Kawamura, N., Tokoeda, Y., Oshima, M., Okahata, H., Tsutsumi, H., Van Doorn, L.J., Muto, H., Smolenov, I., Suryakiran, P.V., Han, H.H.: Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life. Vaccine 29(37), 6335–6341 (2011)CrossRefPubMed
10.
Phua, K.B., Lim, F.S., Lau, Y.L., Nelson, E.A., Huang, L.M., Quak, S.H., Lee, B.W., Teoh, Y.L., Tang, H., Boudville, I., Oostvogels, L.C., Suryakiran, P.V., Smolenov, I.V., Han, H.H., Bock, H.L.: Safety and efficacy of human RV vaccine during the first 2 years of life in Asian infants: randomized, double-blind, controlled study. Vaccine 27(43), 5936–5941 (2009)CrossRefPubMed
11.
Ruiz-Palacios, G.M., Perez-Schael, I., Velazquez, F.R., Abate, H., Breuer, T., Clemens, S.C., Cheuvart, B., Espinoza, F., Gillard, P., Innis, B.L., Cervantes, Y., Linhares, A.C., López, P., Macías-Parra, M., Ortega-Barría, E., Richardson, V., Rivera-Medina, D.M., Rivera, L., Salinas, B., Pavía-Ruz, N., Salmerón, J., Rüttimann, R., Tinoco, J.C., Rubio, P., Nuñez, E., Guerrero, M.L., Yarzábal, J.P., Damaso, S., Tornieporth, N., Sáez-Llorens, X., Vergara, R.F., Vesikari, T., Bouckenooghe, A., Clemens, R., De Vos, B., O’Ryan, M.: Human Rotavirus Vaccine Study Group: safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 354(1), 11–22 (2006)CrossRefPubMed
12.
Vesikari, T., Karvonen, A., Prymula, R., Schuster, V., Tejedor, J.C., Cohen, R., Meurice, F., Han, H.H., Damaso, S., Bouckenooghe, A.: Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, doubleblind controlled study. Lancet 370, 1757–1763 (2007)CrossRefPubMed
13.
Büsch, K., Ezzat, N., Trichard, M., Largeron, N.: Burden of pediatric RV gastroenteritis and potential benefits of a universal vaccination programme in Germany. Value Health 10, A437 (2007)CrossRef
14.
World Health Organization: Rotavirus vaccines: an update. Wkly. Epidemiol. Rec. 84(50), 533–540 (2009)
15.
16.
Uhlig, U., Kostev, K., Schuster, V., Uhlig, H.H.: RV vaccination in Germany: analysis of nationwide surveillance data 2006 to 2010. Pediatr. Infect. Dis. J. 30, e244–e247 (2011)CrossRefPubMed
17.
Mitteilung der Ständigen Impfkomission (STIKO). Empfehlung zur Rotavirus-Standardimpfung von Säuglingen in Deutschland. Bundesgesundheitsbl. 56, 955–956 (2013)
18.
Standaert, B., Gomez, J.A., Raes, M., Debrus, S., Velázquez, F.R., Postma, M.J.: Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed data. PLoS One 8, e53864 (2013)PubMedCentralCrossRefPubMed
19.
20.
Hsu, V.P., Staat, M.A., Roberts, N., Thieman, C., Bernstein, D.I., Bresee, J., Glass, R.I., Parashar, U.D.: Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children. Pediatrics. 115, 78–82 (2005)PubMed
21.
Karsten, C., Baumgarte, S., Friedrich, A.W., von Eiff, C., Becker, K., Wosniok, W., Ammon, A., Bockemuhl, J., Karch, H., Huppertz, H.I.: Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004. Eur. J. Clin. Microbiol. Infect. Dis. 28, 935–943 (2009)PubMedCentralCrossRefPubMed
22.
Ehlken, B., Laubereau, B., Karmaus, W., Petersen, G., Rohwedder, A., Forster, J.: Prospective population-based study on rotavirus disease in Germany. Acta Paediatr. 91, 769–775 (2002)CrossRefPubMed
23.
Van Damme, P., Giaquinto, C., Huet, F., Gothefors, L., Maxwell, M., Van der Wielen, M.: Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004–2005: the REVEAL study. J. Infect. Dis. 195(Suppl 1), S4–S16 (2007)CrossRefPubMed
24.
Robert Koch Institut: Epidemiologie der Rotavirus-Erkrankungen in Deutschland im Zeitraum von 2001 bis 2011. Epid. Bull. 44, 441–449 (2012)
25.
Koch, J., Wiese-Posselt, M., Remschmidt, C., Wichmann, O., Bertelsmann, H., Garbe, E., Hengel, H., Meerpohl, J.J., Mas Marques, A., Oppermann, H., Hummers-Pradier, E., van Kries, R., Mertens, T.: Background paper to the recommendation for routine rotavirus vaccination of infants in Germany. Bundesgesundheitsblatt. 56, 957–984 (2013)CrossRef
26.
27.
28.
29.
30.
31.
Seybolt, L.M., Bégué, R.E.: Rotavirus vaccination and herd immunity: an evidence-based review. Pediatric Health Med. Therapeutics 3, 25–37 (2012)
32.
Bilcke, J., Beutels, P.: Reviewing the cost effectiveness of RV vaccination. Pharmacoeconomics 27(4), 281–297 (2009)CrossRefPubMed
33.
Jit, M., Mangen, M.J., Melliez, H., Yazdanpanah, Y., Bilcke, J., Salo, H., Edmunds, W.J., Beutels, P.: An update to “The cost-effectiveness of RV vaccination: comparative analyses for five European countries and transferability in Europe”. Vaccine 28, 7457–7459 (2010)CrossRefPubMed
34.
Paulke-Korinek, M., Kundi, M., Rendi-Wagner, P., de Martin, A., Eder, G., Schmidle-Loss, B., Vecsei, A., Kollaritsch, H.: Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 29, 2791–2796 (2011)CrossRefPubMed
35.
Bettinger, J.A., Wills, K., Le Saux, N., Scheifele, D.W., Halperin, S.A., Vaudry, W.: Heterogeneity of rotavirus testing and admitting practices for gastroenteritis among 12 tertiary care pediatric hospitals: implications for surveillance. Can. J. Infect. Dis. Med. Microbiol. Spring. 22(1), 15–18 (2011)
36.
Metadata
Title
Recommendation of rotavirus vaccination and herd effect: a budget impact analysis based on German health insurance data
Authors
Alexander Karmann
Andrea Jurack
Daniel Lukas
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 7/2015
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-014-0624-2

Other articles of this Issue 7/2015

The European Journal of Health Economics 7/2015 Go to the issue

Original Paper

Health system characteristics and unmet care needs in Europe: an analysis based on EU-SILC data

Original Paper

Healthy donor effect and satisfaction with health

Original Paper

Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries

Original Paper

Using price–volume agreements to manage pharmaceutical leakage and off-label promotion

Original Paper

Hospital staffing and local pay: an investigation into the impact of local variations in the competitiveness of nurses’ pay on the staffing of hospitals in France

Original Paper

Cost of care for cystic fibrosis: an investigation of cost determinants using national registry data